Search for Clinical Trial Results

Sponsored By

Ovarian Low Malignant Potential Tumor - 24 Studies Found

Status Study
Completed Study Name: Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors
Condition:
  • Fallopian Tube Carcinoma
  • Primary Peritoneal Carcinoma
  • Recu
    Date: 2006-03-09
    Interventions:
    • Drug: Belinostat Given IV
Completed Study Name: Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor
Condition:
  • Fallopian Tube Cancer
  • Ovarian Cancer
  • Primary Peritoneal Ca
    Date: 2002-06-06
    Interventions: Drug: imatinib mesylate
Active, not recruiting Study Name: Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
Condition:
  • Borderline Ovarian Surface Epithelial-stromal Tumor
  • Ovarian Ser
    Date: 2007-10-22
    Interventions:
    • Drug: selumetinib Given PO
Completed Study Name: 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
Condition:
  • Advanced Adult Primary Liver Cancer
  • Carcinoma of the Appendix
  • Drug: 7-hydroxystaurosporine G
Completed Study Name: Collecting Tumor Samples From Patients With Gynecological Tumors
Condition:
  • Borderline Ovarian Clear Cell Tumor
  • Borderline Ovarian Serous Tumor
  • Adnexal Mass
  • Borderline Ovarian Epithelial Tumor
  • Date: 2015-07-30
    Interventions:
    • Drug: Dexamethasone Given PO
Completed Study Name: Gefitinib in Treating Patients With Cervical Cancer
Condition:
  • Cervical Cancer
  • Fallopian Tube Cancer
  • Ovarian Cancer

    • Date: 2002-11-12
    Interventions:
    • Drug: gefitinib
    • Other: immunohistochemistr
Completed Study Name: Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
Condition: Cancer
Date: 2002-09-06
Interventions: Drug: vorinostat
Completed Study Name: Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Condition:
  • Cervical Cancer
  • Endometrial Cancer
  • Fallopian Tube Cancer Date: 2006-09-26
    Interventions: Drug: fondaparinux sodium Fondaparinux, 2.5 mg subcutaneous, Days 1-28 by mouth.
Completed Study Name: Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer
Condition:
  • Cervical Cancer
  • Ovarian Cancer
  • Sarcoma

Date: 2006-09-29
Interventions:
  • Other: counseling intervention
  • Other: stud
Next >>>